Indústrias
Showing 21–30 de 44 resultados
-
Drugs for Helicobacter Pylori Infection Market in China
The drugs for helicobacter pylori infection market in China is set to increase by US$ 5,855 milhões de 2021 para 2027, representing a compound annual growth rate (CAGR) de 14.2% durante o período de previsão.
-
Inhalation Preparations Market in China
The inhalation preparations market in China is poised to grow by US$ 3,951 milhões durante 2021-2027, progredindo em um CAGR de 12.8% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix.
-
Drug for Gastrointestinal Diseases Market in China
According to StrategyHelix, the drug for gastrointestinal diseases market in China is expected to increase by US$ 4,900 milhões durante 2021-2027, expanding at a CAGR of 6.7% durante o período de previsão.
-
Quadrivalent Influenza Vaccine Market in China
The quadrivalent influenza vaccine market in China is set to increase by US$ 2,512 milhões de 2021 para 2027, representing a compound annual growth rate (CAGR) de 20.9% durante o período de previsão.
-
Shingles Vaccine Market in China
The shingles vaccine market in China is poised to grow by US$ 5,886 milhões de 2021 para 2027, registrando um CAGR de 49.2% durante o período de previsão, de acordo com StrategyHelix.
-
HPV Vaccine Market in China
The HPV vaccine market in China is poised to grow by US$ 5,054 milhões de 2021 para 2027, registrando um CAGR de 18.7% durante o período de previsão, de acordo com StrategyHelix.
-
Vaccine Market in China
According to StrategyHelix, the vaccine market in China is expected to increase by US$ 2,663 milhões durante 2021-2027, expanding at a CAGR of 7.7% durante o período de previsão.
-
PD-1 (PD-L1) Therapy Market in China
The PD-1 (PD-L1) therapy market in China is poised to grow by US$ 4,330 milhões durante 2021-2027, progredindo em um CAGR de 12.3% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix.
-
Melanoma Market in China
According to a statistic by StrategyHelix, the melanoma market in China, in terms of volume, is expected to expand at a CAGR of 2.2% in the next five years.
-
Oncolytic Virus Therapy Market in China
The oncolytic virus therapy market in China is poised to grow by US$ 1,913 milhões durante 2021-2027, progredindo em um CAGR de 41.8% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix.